These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 1407880)

  • 41. Effects of two rescue doses of a synthetic surfactant on mortality rate and survival without bronchopulmonary dysplasia in 700- to 1350-gram infants with respiratory distress syndrome. The American Exosurf Neonatal Study Group I.
    Long W; Thompson T; Sundell H; Schumacher R; Volberg F; Guthrie R
    J Pediatr; 1991 Apr; 118(4 Pt 1):595-605. PubMed ID: 2007938
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Changes in pulmonary artery pressure during the acute phase of respiratory distress syndrome treated with three different types of surfactant.
    Hamdan AH; Shaw NJ
    Pediatr Pulmonol; 1998 Mar; 25(3):191-5. PubMed ID: 9556011
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Natural and synthetic surfactant in the treatment of neonatal respiratory distress syndrome].
    Bratlid D; Farstad T
    Tidsskr Nor Laegeforen; 1994 Jan; 114(1):33-6. PubMed ID: 8296279
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Systemic and pulmonary hemodynamics in the course of substitute therapy with exosurf neonatal in newborn infants with respiratory distress syndrome].
    Milenin OB; Efimov MS
    Anesteziol Reanimatol; 1996; (6):7-10. PubMed ID: 9045592
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mucus rheology and transport in neonatal respiratory distress syndrome and the effect of surfactant therapy.
    Rubin BK; Ramirez O; King M
    Chest; 1992 Apr; 101(4):1080-5. PubMed ID: 1555424
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cardiorespiratory and stress hormone responses during first dose surfactant administration in neonates with RDS.
    Chan JO; Moglia BA; Reeves IV; Kim AH; Darrow KA; Seaton JF; Marks KH
    Pediatr Pulmonol; 1994 Apr; 17(4):246-9. PubMed ID: 8208596
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of exogenous pulmonary surfactants on mortality rate in neonatal respiratory distress syndrome: A network meta-analysis of randomized controlled trials.
    Zhang L; Cao HY; Zhao S; Yuan LJ; Han D; Jiang H; Wu S; Wu HM
    Pulm Pharmacol Ther; 2015 Oct; 34():46-54. PubMed ID: 26296793
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Exosurf treatment following wood smoke inhalation.
    Feldbaum DM; Wormuth D; Nieman GF; Paskanik M; Clark WR; Hakim TS
    Burns; 1993 Oct; 19(5):396-400. PubMed ID: 8216766
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of the changes in the a/A oxygen ratio after administration of two surfactants for the treatment of neonatal respiratory distress syndrome.
    Bassiouny MR; Remo C; Cherian E
    J Trop Pediatr; 1997 Feb; 43(1):38-41. PubMed ID: 9078827
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Instillation rate effects of Exosurf on cerebral and cardiovascular haemodynamics in preterm neonates.
    Saliba E; Nashashibi M; Vaillant MC; Nasr C; Laugier J
    Arch Dis Child Fetal Neonatal Ed; 1994 Nov; 71(3):F174-8. PubMed ID: 7820712
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of aerosolized artificial surfactant on repeated oleic acid injury in sheep.
    Zelter M; Escudier BJ; Hoeffel JM; Murray JF
    Am Rev Respir Dis; 1990 Apr; 141(4 Pt 1):1014-9. PubMed ID: 2327634
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Intra-amniotic administration of pulmonary surfactant improves lung ultrastructural pathology and enhances surfactant protein A expression in fetal rabbits with intrauterine infection].
    Wu J; Liu DY; Liu J; Feng ZC
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 May; 29(5):1032-5, 1039. PubMed ID: 19460737
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Partial liquid ventilation in premature lambs with respiratory distress syndrome: efficacy and compatibility with exogenous surfactant.
    Leach CL; Holm B; Morin FC; Fuhrman BP; Papo MC; Steinhorn D; Hernan LJ
    J Pediatr; 1995 Mar; 126(3):412-20. PubMed ID: 7869204
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Spontaneous breathing or mechanical ventilation alters lung compliance and tissue association of exogenous surfactant in preterm newborn rabbits.
    Bohlin K; Bouhafs RK; Jarstrand C; Curstedt T; Blennow M; Robertson B
    Pediatr Res; 2005 May; 57(5 Pt 1):624-30. PubMed ID: 15718361
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Factors affecting the neonatal response to artificial surfactant.
    Skelton R; Jeffery HE
    J Paediatr Child Health; 1996 Jun; 32(3):236-41. PubMed ID: 8827542
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lung mechanics and gas exchange in ventilated preterm infants during treatment of hyaline membrane disease with multiple doses of artificial surfactant (Exosurf).
    Pfenninger J; Aebi C; Bachmann D; Wagner BP
    Pediatr Pulmonol; 1992 Sep; 14(1):10-5. PubMed ID: 1437337
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Exosurf rescue surfactant improves high ventilation-perfusion mismatch in respiratory distress syndrome.
    Billman D; Nicks J; Schumacher R
    Pediatr Pulmonol; 1994 Nov; 18(5):279-83. PubMed ID: 7898965
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effect of a peptide-containing synthetic lung surfactant on gas exchange and lung mechanics in a rabbit model of surfactant depletion.
    van Zyl JM; Smith J; Hawtrey A
    Drug Des Devel Ther; 2013; 7():139-48. PubMed ID: 23507973
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Surfactant for babies.
    Lancet; 1992 Dec; 340(8832):1387. PubMed ID: 1360097
    [No Abstract]   [Full Text] [Related]  

  • 60. Overview of clinical trials comparing natural and synthetic surfactants.
    Halliday HL
    Biol Neonate; 1995; 67 Suppl 1():32-47. PubMed ID: 7647157
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.